As psychedelic medicines like MDMA and psilocybin near potential FDA approval, there is a growing need to train mental health professionals in psychedelic-assisted psychotherapy. This mini-course (75 minutes) provides an overview of the latest research showing the efficacy of psychedelic therapy for depression, anxiety, PTSD, addiction, and more.
Learn about the professional training programs being developed by MAPS and CIIS to prepare therapists to conduct safe, effective psychedelic sessions. Gain insights into neuropharmacology, global traditions, therapist competencies, and clinical best practices around psychedelic healing. An engaging discussion explores how psychedelic therapy is transforming mental healthcare and where it fits into innovative new treatments.
Whether you aim to provide psychedelic therapy or advise interested clients, this mini-course will equip you with knowledge of the research, competencies, and future potential of this emerging field.